Nine-month interim report May – January 2009/10

• Order bookings increased 20* percent.

• Net sales rose 9* percent to SEK 4,835 M (4,156).

• Operating profit increased to SEK 553 M (309).

• Profit after taxes rose to SEK 358 M (184).

• Earnings per share after dilution improved to SEK 3.91 (2.03).

• Postitive cash flow from operating activities, improved to SEK 589 M (neg. 93).
Cash flow after investments was positive SEK 527 M (neg. 207).

• Elekta’s financial outlook remains unchanged with an increase in net sales by more than 8 percent in local currency, and operating profit increase in SEK of more than 35 percent for 2009/10.



* Compared to the first nine months last fiscal year at unchanged exchange rates.


For further information, please contact:
Tomas Puusepp, President and CEO, Elekta AB (publ)
Tel: +46 8 587 25 520, e-mail:  

Håkan Bergström, CFO, Elekta AB (publ)
Tel: +46 8 587 25 547, e-mail:  

Stina Thorman, Vice President Corporate Communications, Elekta AB (publ)
Tel: +46 8 587 25 437, e-mail:  

Elekta AB (publ)
Corporate registration number 556170-4015
Box 7593, SE 103 93 Stockholm, Sweden

Elekta

Elekta is a leading international medical-technology company offering advanced and innovative clinical solutions and services for precision radiation treatment of cancer and minimally invasive treatment of brain disorder...

View more


  CONTACT  
  • Stina Thorman
  • Vice President Corporate Communications
  • +46 8 587 254 37
  •  

Related documents

 
 
 
 
Social Media Pitch:
Nine-month interim report May – January 2009/10